[HTML][HTML] Prognostic factors of MINOCA and their possible mechanisms
M Kong, Z Pei, Y Xie, Y Gao, J Li, G He - Preventive Medicine Reports, 2024 - Elsevier
Objective Despite not showing substantial stenosis of coronary arteries, Myocardial
Infarction with Non-Obstructive Coronary Arteries (MINOCA) presents with myocardial …
Infarction with Non-Obstructive Coronary Arteries (MINOCA) presents with myocardial …
The 10 essential questions regarding lipoprotein (a)
KM Kostner, GM Kostner - Current Opinion in Clinical Nutrition & …, 2024 - journals.lww.com
This review aims to answer important preclinical and clinical questions about the
metabolism and physiological role of Lp (a) and also outlines possible therapeutic …
metabolism and physiological role of Lp (a) and also outlines possible therapeutic …
Antidepressants are complex regulators of lipoprotein (a) macropinocytosis
GMI Redpath, N Deo, H Siddiqui, G Madani… - bioRxiv, 2021 - biorxiv.org
The regulation of Lp (a) clearance from circulation by cellular uptake remains enigmatic.
While multiple receptors have been implicated in Lp (a) uptake, each receptor only partially …
While multiple receptors have been implicated in Lp (a) uptake, each receptor only partially …
Lipoprotein (a) and cardiovascular disease
MB Boffa, ML Koschinsky - Biochemical Journal, 2024 - portlandpress.com
Elevated plasma levels of lipoprotein (a)(Lp (a)) are a prevalent, independent, and causal
risk factor for atherosclerotic cardiovascular disease and calcific aortic valve disease. Lp (a) …
risk factor for atherosclerotic cardiovascular disease and calcific aortic valve disease. Lp (a) …